Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Ohba

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
BMC Urology|May 12, 2026
Risk factors for recurrence following robot-assisted laparoscopic partial nephrectomy (RAPN): a single-center retrospective studyMasaharu Oki, Kojiro Ohba, Tsuyoshi Matsuda, et al.
The Prostate|August 17, 2016
Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo-Adjuvant Hormonal Therapy in Prostate Cancer PatientsAkihiro Asai, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
Lower Urinary Tract Symptoms|August 14, 2019
Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive BladderTomohiro Matsuo, Yasuyoshi Miyata, Kyohei Araki, et al.
In Vivo (Athens, Greece)|June 27, 2024
Relationship Between Overactive Bladder and Bone Fracture Risk in Female PatientsShintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, et al.
Medicines (Basel, Switzerland)|December 23, 2018
Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled TrialKyohei Araki, Yasuyoshi Miyata, Kojiro Ohba, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled StudyYasufumi Ueda, Tomohiro Matsuo, Ken Kawada, et al.
Cancers|December 19, 2014
Met in urological cancersYasuyoshi Miyata, Akihiro Asai, Kensuke Mitsunari, et al.
BMC Urology|July 31, 2016
The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly menTomohiro Matsuo, Yasuyoshi Miyata, Katsura Kakoki, et al.
Anticancer Research|March 2, 2018
Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line ChemotherapyYasuyoshi Miyata, Tomohiro Matsuo, Yuichiro Nakamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 28, 2015
[Clinical analysis of non-clear cell renal cell carcinoma]Kojiro Ohba, Akihiro Asai, Kensuke Mitsunari, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
BMC Urology|May 12, 2026
Risk factors for recurrence following robot-assisted laparoscopic partial nephrectomy (RAPN): a single-center retrospective studyMasaharu Oki, Kojiro Ohba, Tsuyoshi Matsuda, et al.
The Prostate|August 17, 2016
Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo-Adjuvant Hormonal Therapy in Prostate Cancer PatientsAkihiro Asai, Yasuyoshi Miyata, Tomohiro Matsuo, et al.
Lower Urinary Tract Symptoms|August 14, 2019
Efficacy of Tadalafil Therapy and Changes in Oxidative Stress Levels in Male Patients with Lower Urinary Tract Symptoms and Overactive BladderTomohiro Matsuo, Yasuyoshi Miyata, Kyohei Araki, et al.
In Vivo (Athens, Greece)|June 27, 2024
Relationship Between Overactive Bladder and Bone Fracture Risk in Female PatientsShintaro Mori, Tomohiro Matsuo, Hiroyuki Honda, et al.
Medicines (Basel, Switzerland)|December 23, 2018
Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled TrialKyohei Araki, Yasuyoshi Miyata, Kojiro Ohba, et al.
Medicina (Kaunas, Lithuania)|March 29, 2023
The Relationship between the Presence of an Earlobe Crease and Overactive Bladder: A Cross-Sectional Case-Controlled StudyYasufumi Ueda, Tomohiro Matsuo, Ken Kawada, et al.
Cancers|December 19, 2014
Met in urological cancersYasuyoshi Miyata, Akihiro Asai, Kensuke Mitsunari, et al.
BMC Urology|July 31, 2016
The efficacy of mirabegron additional therapy for lower urinary tract symptoms after treatment with α1-adrenergic receptor blocker monotherapy: prospective analysis of elderly menTomohiro Matsuo, Yasuyoshi Miyata, Katsura Kakoki, et al.
Anticancer Research|March 2, 2018
Expression of Class III Beta-tubulin Predicts Prognosis in Patients with Cisplatin-resistant Bladder Cancer Receiving Paclitaxel-based Second-line ChemotherapyYasuyoshi Miyata, Tomohiro Matsuo, Yuichiro Nakamura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 28, 2015
[Clinical analysis of non-clear cell renal cell carcinoma]Kojiro Ohba, Akihiro Asai, Kensuke Mitsunari, et al.
Pageof 14